CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income	$ 49,776	$ 45,325
Net income from discontinued operations	0	100
Net income from continuing operations	49,776	45,225
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	14,285	14,879
Amortization of debt issue costs	385	209
Provision for doubtful accounts	33	921
Share-based compensation	5,679	6,032
Deferred income taxes	932	(109)
Finance lease interest	24	26
Changes in operating assets and liabilities:
Accounts receivable	(49,541)	(54,370)
Inventories	(146,826)	(95,531)
Prepaid expenses and other assets	30,487	(11,236)
Other non-current assets	(7,168)	(1,561)
Accounts payable	33,820	25,444
Accrued expenses and other liabilities	(13,268)	(5,130)
Income taxes payable	6,036	(177)
Net cash used in operating activities	(75,346)	(75,378)
Cash flows from investing activities:
Capital expenditures	(4,262)	(2,645)
Proceeds from the sale of discontinued operations	0	3,125
Net cash (used in) provided by investing activities	(4,262)	480
Cash flows from financing activities:
Borrowings on revolving credit, net of expenses	1,232,058	1,115,161
Repayments on revolving credit, net of expenses	(1,137,897)	(1,057,376)
Borrowings (repayments) on long-term debt, net	17,465	(4,093)
Repayments on finance lease obligation	(492)	(624)
Debt issuance costs	(1,407)	0
Exercise of stock options	634	1,114
Taxes paid on settlement of equity awards	(2,332)	(2,634)
Common stock repurchased	0	(183)
Net cash provided by financing activities	108,029	51,365
Effect of exchange rate changes on cash and cash equivalents	37	(5,062)
Increase (decrease) in cash and cash equivalents	28,458	(28,595)
Cash and cash equivalents at beginning of period	37,987	62,718
Cash and cash equivalents at end of period	$ 66,445	$ 34,123